Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-dose vitamin D supplementation does not improve outcome in a cutaneous melanoma population: results of a randomized double-blind placebo-controlled study (ViDMe trial).
De Smedt J, Van Kelst S, Janssen L, Marasigan V, Boecxstaens V, Bogaerts K, Belmans A, Vanderschueren D, Vandenberghe K, Bechter O, Aura C, Lambrechts D, Strobbe T, Emri G, Nikkels A, Garmyn M. De Smedt J, et al. Among authors: marasigan v. Br J Dermatol. 2024 Nov 18;191(6):886-896. doi: 10.1093/bjd/ljae257. Br J Dermatol. 2024. PMID: 38913652 Clinical Trial.
Vitamin D supplementation in cutaneous malignant melanoma outcome (ViDMe): a randomized controlled trial.
De Smedt J, Van Kelst S, Boecxstaens V, Stas M, Bogaerts K, Vanderschueren D, Aura C, Vandenberghe K, Lambrechts D, Wolter P, Bechter O, Nikkels A, Strobbe T, Emri G, Marasigan V, Garmyn M. De Smedt J, et al. Among authors: marasigan v. BMC Cancer. 2017 Aug 23;17(1):562. doi: 10.1186/s12885-017-3538-4. BMC Cancer. 2017. PMID: 28835228 Free PMC article. Clinical Trial.
Clinical and genetic determinants of vitamin D receptor expression in cutaneous melanoma patients.
De Smedt J, Aura C, Van Kelst S, Janssen L, Marasigan V, Boecxstaens V, Stas M, Bogaerts K, Belmans A, Cleynen I, Vanderschueren D, Vandenberghe K, Bechter O, Nikkels A, Strobbe T, Emri G, Lambrechts D, Garmyn M. De Smedt J, et al. Among authors: marasigan v. Melanoma Res. 2024 Apr 1;34(2):125-133. doi: 10.1097/CMR.0000000000000929. Epub 2024 Feb 13. Melanoma Res. 2024. PMID: 38348498 Free PMC article.
Solar Lentigines are Associated with Better Outcome in Cutaneous Melanoma.
Marasigan V, Güvenç C, Oord JJ, Stas M, Boecxstaens V, Bechter O, Wolter P, Lambrechts D, Garmyn M. Marasigan V, et al. Acta Derm Venereol. 2019 Jul 17;99(12):1154-1159. doi: 10.2340/00015555-3270. Online ahead of print. Acta Derm Venereol. 2019. PMID: 31314121 Free article.
Determinants of 25-hydroxyvitamin D Status in a Cutaneous Melanoma Population.
De Smedt J, Van Kelst S, Janssen L, Marasigan V, Boecxstaens V, Stas M, Vanderschueren D, Guler I, Bogaerts K, Vandenberghe K, Bechter O, Billen J, Nikkels A, Strobbe T, Emri G, Lambrechts D, Garmyn M. De Smedt J, et al. Among authors: marasigan v. Acta Derm Venereol. 2022 Apr 8;102:adv00692. doi: 10.2340/actadv.v102.262. Acta Derm Venereol. 2022. PMID: 35312026 Free PMC article.
Metastatic melanoma in the Mid-West of Ireland: a retrospective review.
Porter E, Timoney I, Byrne B, Marasigan V, Hackett C, Ramsay B, Korpanty G, Ahmad K. Porter E, et al. Among authors: marasigan v. Ir J Med Sci. 2022 Dec;191(6):2481-2485. doi: 10.1007/s11845-021-02912-9. Epub 2022 Jan 8. Ir J Med Sci. 2022. PMID: 34997896 Free PMC article.
15 results